Stock listing
Pmv Pharmaceuticals, Inc.
Selected listing: PMVP · NASDAQ · USD · US
Pmv Pharmaceuticals, Inc. (NASDAQ:PMVP), Health Technology. Latest release Oct 5, 2026: PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors.
- Ticker
- NASDAQ:PMVP
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
About Pmv Pharmaceuticals, Inc.
Pmv Pharmaceuticals, Inc. is a public company traded under the ticker PMVP in the American market. Pmv Pharmaceuticals focuses on developing innovative therapies in the pharmaceutical sector.
Latest news from Pmv Pharmaceuticals, Inc.
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors
October 4, 2026
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors
October 5, 2026
PMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer
September 8, 2026
PMV Pharma Announces Proposed Public Offering of Securities
August 31, 2026
PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial
August 31, 2026
Research Pmv Pharmaceuticals, Inc.
Pmv Pharmaceuticals, Inc. company profile
View the public company page for Pmv Pharmaceuticals, Inc. on 6ix.
Pmv Pharmaceuticals, Inc. news
Read company news and market updates connected to Pmv Pharmaceuticals, Inc..
Pmv Pharmaceuticals, Inc. investor events
Find investor webinars, events, and replay context for Pmv Pharmaceuticals, Inc..